Feedback / Questions
Welireg (belzutifan) - Merck (MSD)
Welireg: Newly added patent in Orange Book
(Orange Book)
-
Jul 7, 2025 -
Expiry on Sep 5, 2034
Patent
•
Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Kidney Cancer • Neuroendocrine Tumor • Oncology • Renal Cell Carcinoma • Solid Tumor
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Jul 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious